投顾周刊：医药赛道迅速蹿红，主题基金迎上报高峰

Group 1 - The pharmaceutical sector is rapidly gaining popularity, with a peak in the reporting of themed funds. Approximately 30 pharmaceutical-themed funds were reported in the second quarter, which is roughly equivalent to the total number of such funds established in 2024. Some industry insiders believe that while the current valuations in the pharmaceutical industry are not low, they have not yet entered a bubble phase. From a capital allocation perspective, as the industry's fundamentals improve, actively managed equity funds are expected to return to standard allocations in the pharmaceutical sector [1][3]. - Equity funds are accelerating their positions in the market. Since June, 47 new equity funds have been established, with several funds that have been active for less than half a month already entering the position-building phase. Industry experts suggest that strong policy support is driving the gradual recovery of market valuations, creating abundant structural investment opportunities in the A-share market, prompting fund managers to seize the opportunity to accelerate their positions [1][3]. - The Loan Prime Rate (LPR) remained unchanged in June. The People's Bank of China announced that the one-year LPR is 3.0% and the five-year LPR is 3.5%, both unchanged from the previous month. Industry insiders believe that the stability of the LPR this month aligns with market expectations after a 10 basis point decrease in both tenors in May [1][3]. Group 2 - The Financial Regulatory Bureau has standardized the dividend insurance market, prohibiting arbitrary increases in dividend levels for competitive purposes. The new regulations require that the necessity, reasonableness, and sustainability of dividend levels be thoroughly justified, aiming to curb "involution-style" competition in the industry, prevent interest margin losses, and promote the long-term stable development of dividend insurance business [2]. Group 3 - Australian funds are reducing their holdings in U.S. Treasury bonds due to concerns over policy risks associated with Donald Trump's administration. Some of Australia's largest investors, managing assets equivalent to $30 billion, have shifted towards reducing their exposure to U.S. sovereign debt, reflecting a cautious stance amid potential policy changes [4].